Replies to post #241893 on Biotech Values

[DewDiligence]

…SBTX could close their doors today - and issue some $7+ to all shareholders...or a healthy double from Friday's close?

Regrettably, that kind of shareholder-friendly resolution to a failed business plan hardly ever happens in the biotech sector. Going back almost 20 years, I can recall only one instance: CABG Medical (#msg-10880880, see bottommost paragraph).